CD4 and tuberculosis: Patients with CD4 50–200/μl or ≥200/μl had significantly higher odds of receiving timely ART than patients with CD4 <50/μl, with adjusted odds ratios of 11.3 (95% confidence interval [CI]: 5.0–25.8) and 10.38 (95% CI: 4.89–22.03), respectively; 71.2% achieved TB cure or treatment completion at six months, but this was not associated with timely ART.